Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
w decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 w » 5 wt (Expand Search)
Showing 61 - 80 results of 66,116 for search '(( 5 w decrease ) OR ((( 5 a decrease ) OR ( 5 ((we decrease) OR (mean decrease)) ))))', query time: 1.00s Refine Results
  1. 61
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 62
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 63
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 65
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Knockdown of ABCG2 in PANC-1 clone cells increases 5-ALA staining.

    Knockdown of ABCG2 in PANC-1 clone cells increases 5-ALA staining. by Noriko Kawai (6694010)

    Published 2019
    Save to List
    Saved in:
  12. 72
    Expression of ABC transporter genes.

    Expression of ABC transporter genes. by Noriko Kawai (6694010)

    Published 2019
    Save to List
    Saved in:
  13. 73
    LuxR G37V has decreased DNA-binding activity.

    LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

    Published 2024
    Save to List
    Saved in:
  14. 74
    Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.docx

    Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.d... by Chantal C. Clark (10684632)

    Published 2021
    Save to List
    Saved in:
  15. 75
    Participants characteristics.

    Participants characteristics. by Sakiko Fukui (387048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    Table S2 from Fin whale singing decreases with increased swimming speed

    Table S2 from Fin whale singing decreases with increased swimming speed by Christopher W. Clark (354702)

    Published 2019
    Save to List
    Saved in:
  17. 77
    Table S2 from Fin whale singing decreases with increased swimming speed.

    Table S2 from Fin whale singing decreases with increased swimming speed. by Christopher W. Clark (354702)

    Published 2019
    Save to List
    Saved in:
  18. 78
    Comparison of W<sub>max</sub> (A), the changes in V<sub>E</sub> (B), and W<sub>VT</sub> (C) among the three oxygen conditions.

    Comparison of W<sub>max</sub> (A), the changes in V<sub>E</sub> (B), and W<sub>VT</sub> (C) among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

    Published 2025
    Save to List
    Saved in:
  19. 79
    Decreased biofilm formation in the Δ<i>tad123</i> mutant cells.

    Decreased biofilm formation in the Δ<i>tad123</i> mutant cells. by Tra-My Duong-Nu (7300970)

    Published 2019
    Save to List
    Saved in:
  20. 80
    Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I.

    Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I. by Yousra El Ghaleb (22075892)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: